Kolexia
Samalin Ludovic Psychiatrie
Samalin Ludovic
Psychiatrie
Hôpital Gabriel Montpied
Clermont-Ferrand, France
220 Activités
150 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Manie Syndrome métabolique X Maladie chronique Maladie aigüe Troubles du sommeil par somnolence excessive COVID-19 Troubles de la veille et du sommeil Troubles de l'endormissement et du maintien du sommeil Alcoolisme

Collaborateurs

Voir plus
Llorca Pierre-Michel
Llorca Pierre-Michel
Chu Psychiatrie, Clermont-Ferrand, France
Courtet Philippe
Courtet Philippe
Hôpital Lapeyronie, Montpellier, France
Leboyer Marion
Leboyer Marion
Hôpital Albert Chenevier, Créteil, France
Bellivier Frank
Bellivier Frank
Hôpital Fernand Widal, Paris, France

Industries

Voir plus
Janssen
79 collaboration(s)
Dernière en 2023
ROVI
4 collaboration(s)
Dernière en 2023
Boehringer Ingelheim
3 collaboration(s)
Dernière en 2023
Otsuka
3 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Decreased telomere length in a subgroup of young individuals with bipolar disorders: replication in the FACE-BD cohort and association with the shelterin component POT1.
Translational psychiatry   01 mars 2024
French Society for Biological Psychiatry and Neuropsychopharmacology (AFPBN) guidelines for the management of patients with partially responsive depression and treatment-resistant depression: Update 2024.
L'Encephale   17 février 2024
French Society for Biological Psychiatry and Neuropsychopharmacology and French-speaking Marcé Society guidelines for the management of mood disorders in women before, during, and after pregnancy.
Archives of women's mental health   17 février 2024
Evaluating the efficacy and safety of the currently available once-every-two months long-acting injectable formulations of aripiprazole for the treatment of schizophrenia or as a maintenance monotherapy for bipolar I disorder in adults.
Expert review of neurotherapeutics   05 février 2024
Incidence and predictors of metabolic syndrome onset in individuals with bipolar disorders: A longitudinal study from the FACE-BD cohort.
Acta psychiatrica Scandinavica   24 janvier 2024
Esketamine-induced post-traumatic stress disorder flashbacks during treatment-resistant depression indication: is it just a side effect?
medRxiv : the preprint server for health sciences   18 janvier 2024
The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review.
Pharmaceutics   13 décembre 2023
Subjects suffering from bipolar disorder taking lithium are less likely to report physical pain: a FACE-BD study.
European psychiatry : the journal of the Association of European Psychiatrists   13 décembre 2023
ShareD-BD: Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder
Essai Clinique (CHU Nîmes)   07 septembre 2023
Development of the PREMIUM computerized adaptive testing for measuring the access and care coordination for patients with severe mental illness.
Psychiatry research   01 septembre 2023